StonvexLoading…
StonvexStonvexStonvexCore line items from PRCT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $308.05M | $224.50M | $136.19M | $75.01M |
Operating Income | $-103.86M | $-96.61M | $-109.17M | $-80.72M |
Net Income | $-95.57M | $-91.41M | $-105.90M | $-87.15M |
EPS (Diluted) | $-1.72 | $-1.75 | $-2.24 | $-1.96 |
Total Assets | $508.08M | $534.02M | $404.72M | $309.33M |
Total Liabilities | $142.21M | $131.80M | $123.97M | $112.26M |
Cash & Equivalents | $286.50M | $333.73M | $257.22M | $221.86M |
Free Cash Flow OCF − CapEx | $-58.34M | $-103.62M | $-133.21M | $-83.03M |
Shares Outstanding | 56.32M | 54.72M | 50.77M | 44.40M |